[Health data protection: the challenge of legislative harmonization in Latin America].

The protection of personal data in health systems requires special measures and procedures to ensure that the privacy of the information is not violated. Advances in digital technology and access to real-time transmission of personal, family, clinical, and laboratory data of patients and/or study subjects may compromise the protection of this information. The privacy of personal data in health in times of pandemic has meant a greater challenge, that is why this unique contribution is presented, whose objective is to identify the ethical and regulatory safeguards in terms of data protection to guarantee full respect for the privacy rights of people and the confidentiality of their data, under the context of health care, especially in conditions of health crisis, such as the one experienced during the SARS-CoV-2 pandemic.

[Humanization: A Conceptual and Attitudinal Problem].

The exercise of medicine has changed since its beginnings up to the present day. Technological advances and changes in the management of the health service caused a distance between the patient and the doctor. On the other hand, professionals prefer to not have their own patients, but rather to strictly adhere to the diagnosis or treatment (specialists) without involving or committing themselves.

[Between Huxley and Orwell: Big Data and Health].

When in 1966 the United Nations stated in its International Covenant on Civil and Political Rights, the ideal of a free human being with respect to his privacy through the prohibition of arbitrary interference in his private life, it was not possible to imagine the impact of global unlimited connectivity, autonomy of new information technologies, the development of huge interconnected databases, the independent and unrestricted circulation of data, which have led to ethical and legal questions arising from this to treat personal and health data.

[Ethical considerations regarding the communication of diagnosis of prodromal Alzheimer's disease].

Population aging has increased age-related diseases such as dementia, Alzheimer's disease (AD) being the most common in older adults (50%-60%). It is one of the most feared conditions for its irreversible and incurable, by its chronicity and it consists of a long process of depersonalization. The clinical diagnosis is mainly based on DSM-IV and NINCDS-ADRDA.

A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.

Purpose: In an effort to reduce the frequency of central nervous system (CNS) progression in patients with metastatic melanoma with ongoing systemic response to biochemotherapy, we modified our standard concurrent biochemotherapy regimen by replacing dacarbazine (DTIC) with oral temozolomide.

Experimental Design: Patients received cisplatin, vinblastine, and temozolomide (20 mg/m(2) cisplatin and 1.2 mg/m(2) vinblastine i.

New agents and future directions in biotherapy.

Many new biotherapy agents to treat cancer are being studied as single agents and in combination with conventional cancer therapy, such as chemotherapy. These agents include the monoclonal antibodies, rituximab, trastuzumab, alemtuzumab, and IMC-C225. Radioimmunotherapy, a type of biotherapy that combines a radioactive isotope with a monoclonal antibody, also is being studied and has shown promise in the treatment of lymphoma.